Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
NCT ID: NCT06251830
Last Updated: 2024-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
610 participants
OBSERVATIONAL
2018-09-01
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MR Fingerprinting: A Novel Sequence Applied to Neuroimaging
NCT03800537
Novel MRI Sequence- MR Fingerprinting
NCT03722459
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
NCT00730002
Accurate Diagnosis of Multiple Sclerosis Using PET/MR
NCT04521439
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00099307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The advantages of a fast, motion-resistant quantitative scan are not limited to paediatrics but could see wide application.
Disorders of movement such as tremor-dominant Parkinson's disease and severe cognitive impairments such as Alzheimer's disease represent a big challenge when referred to MRI. Although MRI is not a major player in diagnosing such diseases, these patients often require an exam in order to exclude other pathologies with similar clinical manifestations and to diagnose or follow-up other concomitant conditions. Patients with expansive intracranial lesions or requiring frequent follow-up, like those affected by inflammatory disease of the central nervous system, need to undergo long and demanding procedures, and they can eventually get into significant distress. The image quality of standard MRI with these challenging patient groups is often poor, as they cannot lay still or are unable to follow instructions. The investigators' second hypothesis is that MRF can be used to increase diagnosis rates of exams in difficult adult populations, reducing the time spent in the scanner and thus reducing wasted procedures and cost, and increasing patient comfort.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pediatric patients
Pediatric patients referred to the participating imaging centre for a standard MRI procedure.
MRI exam with Magnetic Resonance Fingerprinting
Acquisition of MRI data with technique "Magnetic Resonance Fingerprinting"
Adult Patients
Adult patients referred to the participating imaging centre for a standard MRI procedure, with neurological signs and symptoms.
MRI exam with Magnetic Resonance Fingerprinting
Acquisition of MRI data with technique "Magnetic Resonance Fingerprinting"
Healthy Controls
Adult healthy controls
MRI exam with Magnetic Resonance Fingerprinting
Acquisition of MRI data with technique "Magnetic Resonance Fingerprinting"
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI exam with Magnetic Resonance Fingerprinting
Acquisition of MRI data with technique "Magnetic Resonance Fingerprinting"
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients referred to the participating imaging centres for a standard MRI procedure;
* adult healthy controls.
Exclusion Criteria
4 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero, Universitaria Pisana
OTHER
IRCCS Fondazione Stella Maris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mauro Costagli
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliero Universitaria Pisana
Pisa, , Italy
IRCCS Stella Maris
Pisa, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GR-2016-02361693
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
GR-2016-02361693
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.